10.24335/L27478
RoyaltyStat
Collaborative research, with exclusive patent, know-how and process license to make, have made, use, import, offer, sell, market and sublicense pharmaceutical composition in any form or dosage, including in a vial, based on a humanized anti-C5 monoclonal antibody, with intended indications to treat patients undergoing cardiopulmonary bypass procedures, to treat acute myocardial infarction, and any other acute cardiovascular application.
RoyaltyStat
1999